-
公开(公告)号:EP3981774A1
公开(公告)日:2022-04-13
申请号:EP21206477.8
申请日:2017-09-21
IPC分类号: C07F9/6558 , A61K31/675 , A61P9/00 , A61P9/10 , A61P27/02
摘要: The invention relates to crystalline forms of 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester hydrochloride, processes for the preparation thereof, pharmaceutical compositions comprising said crystalline forms, pharmaceutical compositions prepared from such crystalline forms and their use as a medicament, especially as a P2Y 12 receptor antagonist.
-
公开(公告)号:EP3515924A1
公开(公告)日:2019-07-31
申请号:EP17771436.7
申请日:2017-09-21
IPC分类号: C07F9/6558 , A61K31/675 , A61P9/00
-
公开(公告)号:EP4370525A2
公开(公告)日:2024-05-22
申请号:EP22748321.1
申请日:2022-07-11
发明人: BLUMER, Nicole , CLAVEAU, Romain , FEYEN, Fabian , HALL, Leanne , HUGHES, Stephen , REBER, Stefan
IPC分类号: C07F9/6558
CPC分类号: C07F9/65583 , C07B2200/1320130101
-
-